181 related articles for article (PubMed ID: 33671448)
1. Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.
Johansen ML; Perera R; Abenojar E; Wang X; Vincent J; Exner AA; Brady-Kalnay SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671448
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Near-Infrared Imaging Agents Targeting the PTPmu Tumor Biomarker.
Johansen ML; Vincent J; Rose M; Sloan AE; Brady-Kalnay SM
Mol Imaging Biol; 2023 Aug; 25(4):744-757. PubMed ID: 36695968
[TBL] [Abstract][Full Text] [Related]
3. PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma.
Covarrubias G; Johansen ML; Vincent J; Erokwu BO; Craig SEL; Rahmy A; Cha A; Lorkowski M; MacAskill C; Scott B; Gargesha M; Roy D; Flask CA; Karathanasis E; Brady-Kalnay SM
Nanomedicine; 2020 Aug; 28():102216. PubMed ID: 32413511
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agents.
Gao Y; Hernandez C; Yuan HX; Lilly J; Kota P; Zhou H; Wu H; Exner AA
Nanomedicine; 2017 Oct; 13(7):2159-2168. PubMed ID: 28603079
[TBL] [Abstract][Full Text] [Related]
5. Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability
Perera RH; Abenojar E; Nittayacharn P; Wang X; Ramamurthy G; Peiris P; Bederman I; Basilion JP; Exner AA
Nanotheranostics; 2022; 6(3):270-285. PubMed ID: 35223380
[TBL] [Abstract][Full Text] [Related]
6. Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.
Yang H; Zhou T; Cai W; Yi X; Liu X; Wang Y; Zhang L; Duan Y
Tumour Biol; 2016 Oct; 37(10):14153-14163. PubMed ID: 27539728
[TBL] [Abstract][Full Text] [Related]
7. Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.
Wu H; Abenojar EC; Perera R; De Leon AC; An T; Exner AA
Ultrasound Med Biol; 2019 Sep; 45(9):2502-2514. PubMed ID: 31248638
[TBL] [Abstract][Full Text] [Related]
8. Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor.
Yang H; Cai W; Xu L; Lv X; Qiao Y; Li P; Wu H; Yang Y; Zhang L; Duan Y
Biomaterials; 2015 Jan; 37():279-88. PubMed ID: 25453958
[TBL] [Abstract][Full Text] [Related]
9. Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu.
Burden-Gulley SM; Qutaish MQ; Sullivant KE; Tan M; Craig SE; Basilion JP; Lu ZR; Wilson DL; Brady-Kalnay SM
Int J Cancer; 2013 Apr; 132(7):1624-32. PubMed ID: 22987116
[TBL] [Abstract][Full Text] [Related]
10. Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.
Wu H; Rognin NG; Krupka TM; Solorio L; Yoshiara H; Guenette G; Sanders C; Kamiyama N; Exner AA
Ultrasound Med Biol; 2013 Nov; 39(11):2137-46. PubMed ID: 23932272
[TBL] [Abstract][Full Text] [Related]
11. Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model.
Mai L; Yao A; Li J; Wei Q; Yuchi M; He X; Ding M; Zhou Q
PLoS One; 2013; 8(4):e61224. PubMed ID: 23637799
[TBL] [Abstract][Full Text] [Related]
12. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
[TBL] [Abstract][Full Text] [Related]
14. CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors.
Zhu L; Wang L; Liu Y; Xu D; Fang K; Guo Y
Int J Nanomedicine; 2018; 13():6481-6495. PubMed ID: 30410333
[TBL] [Abstract][Full Text] [Related]
15. A PTPmu Biomarker is Associated with Increased Survival in Gliomas.
Johansen ML; Vincent J; Gittleman H; Craig SEL; Couce M; Sloan AE; Barnholtz-Sloan JS; Brady-Kalnay SM
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091655
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.
Johansen ML; Gao Y; Hutnick MA; Craig SEL; Pokorski JK; Flask CA; Brady-Kalnay SM
Anal Chem; 2017 Jun; 89(11):5932-5939. PubMed ID: 28481080
[TBL] [Abstract][Full Text] [Related]
18. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer.
Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P
Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678
[TBL] [Abstract][Full Text] [Related]
19. Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs.
Zhu L; Guo Y; Wang L; Fan X; Xiong X; Fang K; Xu D
J Nanobiotechnology; 2017 Sep; 15(1):63. PubMed ID: 28962657
[TBL] [Abstract][Full Text] [Related]
20. The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging.
Cai WB; Yang HL; Zhang J; Yin JK; Yang YL; Yuan LJ; Zhang L; Duan YY
Sci Rep; 2015 Sep; 5():13725. PubMed ID: 26333917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
